ANN ARBOR - Eran Bashan, CEO of Hygieia, explains how his d-Nav program takes the guesswork out of insulin dosing for people who inject daily. It automates insulin dose prescribing using AI and patented technology in an FDA-cleared mobile app. The program includes clinical care support either virtually, or in a Hygieia clinic. The app
LIVONIA - With coronavirus infection rates fluctuating throughout the United States, millions of people with Type 2 diabetes and uncontrolled blood sugar levels remain at elevated risk for serious complications from the disease. In response, physician specialists and scientists from Hygieia have introduced a fully virtual option for their d-Nav® Insulin Management Program. “Ninety percent
ANN ARBOR – Hygieia, a digital insulin enhancement company, announced that it has signed a distribution agreement with Spirit Healthcare, Ltd. to expand accessibility to the d-Nav Insulin Guidance Service across the United Kingdom. Under the agreement, Spirit will license and become a local distributor of the d-Nav Service and other tools developed by Hygieia
